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Abstract
Background: Type 2 diabetes is associated with increased plasma concentrations of non-esterified fatty acids
(NEFAs), which trigger pancreatic β-cell dysfunction and apoptosis. Only long-chain saturated NEFAs induced
lipotoxicity in rat insulin-producing cells in in vitro experiments, whereas unsaturated NEFAs were not toxic. Some
unsaturated NEFAs even protected against lipotoxicity. In former studies it was suggested that long-chain unsaturated
NEFAs, which induce the formation of lipid droplets, can cause sequestration of palmitic acid into lipid droplets. In the
present structure-activity-relationship study the correlation between lipid droplet formation and the protection
against palmitic acid induced lipotoxicity by unsaturated NEFAs in rat insulin-producing cells was examined.
Methods: Rat insulin-producing RINm5F and INS-1E tissue culture cells were incubated in the presence of
palmitic acid and unsaturated NEFAs with different chain lengths and different numbers of double bonds. The
expression of the lipid droplet associated proteins perilipin 1 and 2 was repressed by the shRNA technique and
the expression analyzed by qRT-PCR and Western blotting. Viability was measured by MTT assay and the
accumulation of lipid droplets was quantified by fluorescence microscopy after Oil Red O staining.
Results: Long-chain unsaturated NEFAs strongly induce the formation of lipid droplets in rat insulin-producing
RINm5F and INS-1E cells. In RINm5F cells incubated with 11-eicosenoic acid (C20:1) 27 % of the cell area was
covered by lipid droplets corresponding to a 25-fold increase in comparison with control cells. On the other hand
the saturated NEFA palmitic acid only induced minor lipid droplet formation. Viability analyses revealed only a
minor toxicity of unsaturated NEFAs, whereas the cells were markedly sensitive to palmitic acid. Long-chain
unsaturated NEFAs antagonized palmitic acid induced lipotoxicity during co-incubation, whereby no
correlation existed between protection and the ability of lipid droplet formation. Perilipin 1 and 2 expression
was decreased after incubation with C20:1 to about 80 % by shRNA. For the protective effect of long-chain
unsaturated NEFAs against lipotoxicity of saturated NEFAs repression of perilipin was not of crucial importance.
Conclusions: Long-chain unsaturated fatty acids protected rat insulin-producing cells against lipotoxicity of saturated
fatty acids. This protective effect was not dependent on lipid droplet formation. Thus lipid droplet formation is
apparently not essential for the protective effect of unsaturated NEFAs against palmitic acid toxicity.
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Background
Type 2 diabetes mellitus (T2DM) is one of the most
prevalent metabolic diseases worldwide caused by in-
sulin resistance of the peripheral tissues and impaired
insulin secretion of pancreatic β-cells [1]. Physical in-
activity and hypercaloric diets, rich in carbohydrates
and saturated fats, are thought to be responsible for an
increase in body weight and can cause the metabolic
syndrome [2–4], which is characterized by obesity,
hypertension and dyslipidemia, and often precedes the
manifestation of T2DM. Chronically elevated plasma
levels of non-esterified fatty acids (NEFAs), which are
associated with the metabolic syndrome [5], can sup-
press insulin secretion and cause β-cell dysfunction
and loss by apoptosis. This so-called lipotoxicity is sub-
ject to intensive research and scientific debate. Only
long-chain saturated NEFAs induce lipotoxicity in ro-
dent insulin-producing cells in in-vitro experiments,
whereas unsaturated NEFAs are not toxic [6]. Short-
and medium-chain fatty acids are metabolized in the
mitochondrial β-oxidation, whereas long-chain fatty
acids can be metabolized in the mitochondria but also
in the peroxisomes when cells were exposed to high
NEFA concentrations [7, 8]. Very long-chain fatty acids
are exclusive substrates for the peroxisomal β-oxidation
[8–10]. The electron transfer in the first step of the per-
oxisomal β-oxidation catalyzed by the enzyme acyl-
CoA-oxidase results in high concentrations of hydrogen
peroxide, which can cause cellular damage [8]. In con-
trast to other cell types pancreatic β-cells do not ex-
press the H2O2 inactivating enzyme catalase [11, 12].
This can explain why long-chain saturated fatty acids
are harmful to rat insulin-producing β-cells and can
cause apoptosis [7].
On the other hand unsaturated NEFAs are not toxic
to rat insulin-producing cells and can even protect
against lipotoxicity. The molecular mechanism of pro-
tection has not yet been fully elucidated, but experi-
mental evidence has been provided that the formation
of lipid droplets (LDs) by unsaturated NEFAs may be
involved in the protection against lipotoxicity [13]. Spe-
cifically it has been suggested that long-chain unsatur-
ated NEFAs can induce the formation of LDs, which
may allow the sequestration of the toxic NEFA palmitic
acid (PA) into these droplets. NEFAs converted into tri-
glycerides and stored in LDs have been considered to
be less toxic than NEFAs, which are readily metabolized
[13]. For the formation of LDs perilipins are crucially
important [14–17]. These proteins are associated with
the LD surface and protect the stored triglycerides
against hydrolysis by the hormone-sensitive lipases.
Perilipins are thus important regulators of intracellular
lipid storage [18, 19]. In the present study we therefore
suppressed perilipin 1 and 2 expression in rat insulin-
producing cell lines using the shRNA technique and
analyzed the effects on LD formation and PA-induced
toxicity. In a comprehensive approach we correlated
the structural requirements of saturated and unsatur-
ated NEFAs with different chain lengths between C12
and C24 with respect to LD formation and toxicity in
rat insulin-producing cells.
Our results show that unsaturated NEFAs were able to
antagonize palmitic acid induced lipotoxicity. However, we
observed no correlation between protection and the ability
of lipid droplet formation in rat insulin-producing cells.
Methods
Tissue culture of insulin-producing cells
The stable insulin-producing RINm5F cell line was estab-
lished from a radiation-induced rat islet cell tumor by
Gazdar et al. [20] and purchased from ATCC (American
Type Culture Collection, Manassas, VA, USA; order#
ATCC CRL-11605). Cells were cultured in RPMI 1640
medium supplemented with 10 mM glucose, 10 % (v/v)
fetal calf serum (Biowest, Nuaillé, France), penicillin and
streptomycin in a humidified atmosphere at 37 °C and 5 %
CO2 [12]. The insulin-producing INS-1E cell line was
clonally selected from a radiation-induced rat insulinoma
and showed a stable phenotype for more than 100 pas-
sages [21, 22]. INS-1E cells were kindly provided by Prof.
Claes Wollheim (University of Geneva, Switzerland).
These cells were cultured in RPMI 1640 medium sup-
plemented with 10 mM glucose, 10 % fetal calf serum
(FCS), penicillin and streptomycin, 10 mM Hepes
(Serva, Heidelberg, Germany), 2 mM glutamine, 1 mM
sodium-pyruvate (Sigma-Aldrich, Munich, Germany),
and 50 μM of 2-mercaptoethanol in a humidified at-
mosphere at 37 °C and 5 % CO2.
NEFA incubation
For NEFA incubations a 50 mM stock solution was
freshly prepared using 90 % ethanol as a solvent. NEFAs
are bound to fatty acid free bovine serum albumin (BSA)
in RPMI 1640 culture medium supplemented with 1 %
fetal calf serum. The ratio between NEFA and BSA is
0.5 mM NEFA to 1 % BSA. For other NEFA concentra-
tions the BSA concentration is adapted according to
this ratio. C12:0 (dodecanoic acid/lauric acid), C12:1
(cis-5-dodecenoic acid), C14:0 (tetradecanoic acid/myr-
istic acid), C14:1 (cis-9-tetradecenoic acid/myristoleic
acid), C16:0 (hexadecanoic acid/palmitic acid), C16:1
(cis-9-hexadecenoic acid/palmitoleic acid), C18:0 (octa-
decanoic acid/stearic acid), C18:1 (cis-9-octadecenoic
acid/oleic acid), C18:2 (cis-9, 12-octadienoic acid/lino-
leic acid), α-C18:3 (cis-9, 12, 15-octatrienoic acid/
alpha-linolenic acid), γ-C18:3 (cis-6, 9, 12-octatrienoic
acid/gamma-linolenic acid), C18:4 (cis-6, 9, 12, 15-
octatetraenoic acid/stearidonic acid), C20:0 (eicosanoic
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acid/arachidic acid), C20:1 (cis-11-eicosenoic acid/gon-
doic acid), C20:2 (cis-11, 14-eicosadienoic acid), C20:3
(cis-8, 11, 14-eicosatrienoic acid), C20:4 (cis-5, 8, 11,
14-eicosatetraenoic acid/arachidonic acid), C20:5 (cis-5,
8, 11, 14, 17-eicosapentaenoic acid), C22:0 (docosanoic
acid/behenic acid), C22:1 (cis-13-docosenoic acid/eru-
cic acid), C22:2 (cis-13, 16-docosadienoic acid), C22:4
(cis-7, 10, 13, 16-docosatetraenoic acid), C22:6 (cis-4, 7,
10, 13, 16, 19-docosahexaenoic acid), C24:0 (tetracosa-
noic acid/lignoceric acid), C24:1 (cis-15-tetracosenoic
acid/nervonic acid) were purchased from Sigma-Aldrich
(Munich, Germany) or Larodan (Malmö, Sweden).
Lipid droplet staining with Oil Red O
RINm5F cells were cultured for 24 h and afterwards ex-
posed to 100 μM of different unsaturated NEFAs with
different chain lengths and different numbers of double
bonds (C18:1 to 18:4, C20:1 to C20:5, C22:1 to C22:6)
for another 24 h. Cells were trypsinized and fixed in
paraformaldehyde for 15 min at room temperature.
Thereafter cells were stained with Oil Red O solution
(Sigma-Aldrich, Munich, Germany) and washed twice
with PBS (phosphate buffered saline). Lipid droplet for-
mation was analyzed by fluorescence microscopy and
the area within the cells was quantified by the use of
the Olympus xcellence software (Olympus, Hamburg,
Germany) at 546 nm excitation and 580 nm emission.
For each incubation condition five to seven coinciden-
tally selected images, each containing 30 to 100 cells,
were used to quantify the proportion of the lipid drop-
let area to the total cell area with the phase analysis
module of the xcellence software.
Assessment of cell viability
RINm5F insulin-producing cells were seeded at 2.5 ×
104 cells/well in 100 μl culture medium onto 96-well
plates and allowed to attach for 24 h before they were
incubated at 37 °C with combinations of different unsat-
urated NEFAs and PA (palmitic acid/hexadecanoic acid/
C16:0) for further 24 h. Cell viability and the ability to
protect against PA-induced toxicity was determined by a
microplate-based MTT assay (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide, Serva, Heidelberg,
Germany) [23].
Lentivirus preparation and transduction of
insulin-producing cells
Lentiviral vector particles were produced as described
[24]. In brief, 5x106 293FT cells were transfected with
the packaging plasmid pPAX2 (37.5 μg), the envelope
plasmid pcDNA-MDG (7.5 μg), and the transfer plas-
mids pLV-U6-sh-rPlin1, pLV-U6-sh-rPlin2 or pLV-U6-
sh-NTC (22.5 μg) by calcium phosphate precipitation.
The transfer plasmids were produced by Sirion Biotech
(Munich, Germany) and validated for suppression effi-
ciencies > 85 %. The virus particles were harvested from
the culture medium 48 h after transfection and purified
by ultrafiltration columns at 3000 g for 25 min (Amicon
Ultra Ultracel-100 K, Millipore, Schwalbach, Germany).
Virus titers (typically 5x107 infectious particles) were
quantified by a TaqMan qPCR assay as described else-
where [24]. RINm5F-Tet3G and INS-1E-Tet3G cells
were transduced with either the sh-rPlin1, sh-rPlin2 or
sh-NTC virus with a multiplicity of infection (MOI)
followed by a selection with puromycin (2.5 μg/ml).
Gene expression analyses
RNA from RINm5F and INS-1E cells was isolated with the
RNeasy Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. The quality of the total RNA
was verified by comparing the intensities of the 28S and
18S rRNA bands in agarose gel electrophoresis. Two
microgram total RNA was reverse transcribed into cDNA
using the RevertAid H Minus M-MuLV Reverse Tran-
scriptase (Thermo Fisher Scientific, Schwerte, Germany)
and random hexamer primers (Life Technologies,
Karlsruhe, Germany). The Plin1 or Plin2 expression in
10 ng cDNA was quantified by a SYBR Green based
assay (GoTaq Green Master Mix; Promega, Mannheim,
Germany) and performed on an Opticon fluorescence de-
tection system (Biorad, Munich, Germany) with the follow-
ing protocol: Samples were initially denaturated at 95 °C for
2 min followed by up to 40 PCR cycles. Each PCR cycle
comprised a denaturation at 94 °C for 30 s, an annealing at
60 °C for 30 s, and an extension at 72 °C for 30 s. The spe-
cificity of the amplification was verified by melting point
analysis. For each sample amplification was performed in
triplicate. The Plin1 and Plin2 expression data were nor-
malized against the geometric mean of the three reference
genes actin beta (Actb), peptidylprolyl isomerase A (PPIA),
and TATA box binding protein (TBP) with the software
qBasePlus (Biogazelle, Zwijnaarde, Belgium). Primers for
qPCR analyses were synthesized by Life Technologies
(Karlsruhe, Germany): Plin1-fw (5′ GATTCTGCTTTGCA
GCGTGAA 3′), Plin1-rv (5′ CAGGACTCTCTGGAGCA
CATTC 3′), Plin2-fw (5′ TCGTCTCTCAGCTCTCCTGT
3′), Plin2-rv (5′ TAGGTGGAGCTCACCAAGGG 3′),
Actb-fw (5′ GCGTCCACCCGCGAGTACAA 3′), Actb-fw
(5′ TTGCACATGCCGGAGCCGTT 3′), PPIA-fw (5′ TT
GCAGACGCCGCTGTCTCTT 3′), PPIA-rv (5′ TGGAA
CTTTGTCTGCAAACAGCTCG 3′) TBP-fw (5′ CAGCT
CGGCGCACCGTACAT 3′), TBP-rv (5′ TCTGGGTTAT
CGTCACGCACCA 3′).
Western blot analyses
Whole cell extracts were prepared in radioimmune pre-
cipitation assay buffer according to the manufacturer’s
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recommendation (Sigma) supplemented with complete
protease inhibitor mixture (Roche Diagnostics, Mannheim,
Germany). Protein content was determined by the BCA
assay (Thermo Fisher Scientific, Rockford, IL, USA).
30 μg of total protein were separated by a 10 % SDS-
PAGE and electroblotted to nitrocellulose membranes
(GE Healthcare, Buckinghamshire, UK). Nonspecific
binding sites of the membranes were blocked with 5 %
nonfat dry milk for 1 h at room temperature. The
membranes were incubated with specific primary anti-
bodies overnight at 4 °C. The following antibodies from
Santa Cruz Biotechnology (Santa Cruz, CA, USA) were
used: anti-Perilipin 1 (H-300, diluted 1:2000), anti-
Perilipin 2 (H-80, diluted 1:200), and anti-β-actin (sc-
1615, diluted 1:250). The excess of primary antibody
was removed by three washing steps with washing buf-
fer (PBS, 0.1 % Tween 20, 0.1 % BSA). Subsequently,
the membranes were incubated with peroxidase-labeled
secondary anti-rabbit antibodies at a dilution of 1:20,000
at room temperature for 1 h. Protein bands were visual-
ized by chemiluminescence using the ECL detection sys-
tem (GE Healthcare). As a loading control the expression
of β-actin was analyzed after stripping the blots with Re-
blot Pus solution (Merck-Millipore, Darmstadt, Germany)
according to the manufacturer’s manual. Protein band in-
tensity was quantified and normalized to β-actin though
densitometry with the Gel-Pro Analyzer program (version
6.0, Media Cybernetics, Silver Spring, MD, USA).
Statistical analysis
Data are expressed as means ± SEM. Statistical ana-
lyses were performed using ANOVA plus Dunnett’s or
Bonferroni’s test for multiple comparisons, unless stated
otherwise (GraphPad Prism5, San Diego, CA, USA).
Results
Induction of lipid droplet formation by NEFAs in
insulin-producing cells
Long-chain monounsaturated NEFAs (C18:1, C20:1,
C22:1) strongly induced the formation of LDs in rat
insulin-producing RINm5F cells. More than 25 % of the
cell area of RINm5F cells incubated with the long-chain
NEFA gondoic acid (C20:1, 100 μM) was covered by
LDs, which corresponds to a 16-fold increase in
comparison to untreated cells. On the other hand incu-
bation with medium-chain and long-chain monoun-
saturated NEFAs (C12:1, C14:1, C16:1) and with a very
long-chain NEFA (C24:1) showed no significant in-
crease in LD formation in comparison to control cells
(Fig. 1). In contrast to unsaturated NEFAs none of the
analyzed saturated NEFAs (C12:0 to C24:0) caused sig-
nificant increases in LD content in RINm5F cells.
Effect of saturation level of unsaturated NEFAs on lipid
droplet formation in insulin-producing cells
In the group of unsaturated NEFAs with the chain
length of C18 with different numbers of double bonds
(C18:x) only C18:1 and C18:2 revealed a significant up
to 15 % increase in the cell area covered with LDs
(Fig. 2a). However, the unsaturated NEFAs C18:3 and
C18:4 showed no increase in LD formation compared to
the control condition. With 27 % LDs of the cell area
C20:1 induced maximal lipid droplet formation. With an
increasing number of double bonds the LD area declined
to < 4 % after incubation with C20:4 or C20:5 (Fig. 2b),
which was not significantly higher than in the control
condition. The unsaturated C22:x NEFA group revealed
the same tendency with the greatest LD formation after
incubation with the monounsaturated C22:1 and a steady
decrease with increasing numbers of double bonds up to
C22:6 (Fig. 2c).
Antagonistic effect of saturated fatty acids against lipid
droplet formation
Long-chain unsaturated NEFAs induced LD formation,
whereas long-chain saturated NEFAs were not able to
form LDs. A co-incubation experiment of both saturated
and unsaturated NEFAs revealed a decline of LD forma-
tion typically induced by long-chain unsaturated NEFAs.
Palmitic acid (C16:0), which is the physiologically and
nutritionally most important saturated fatty acid, antago-






































































Fig. 1 Lipid droplet formation in rat insulin-producing RINm5F cells
after incubation with saturated and monounsaturated NEFAs of
increasing chain length. RINm5F cells were incubated with different
medium- and long-chain saturated and monounsaturated NEFAs
(100 μM) for 24 h. Thereafter cells were fixed and stained with Oil
Red O. Lipid droplet formation was analyzed by fluorescence microscopy
and quantified using the software xcellence rt. Data are means ±
SEM of n = 3. ***p < 0.001 compared to control cells (Dunnett’s
Multiple Comparison Test). #p < 0.05, ##p < 0.01, ###p < 0.005 compared
to saturated NEFA with the same chain length (Student’s t-test)
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by C20:1 (Fig. 3a-b). The antagonistic effect increased
with the increase of the proportion of C16:0 in the mix-
tures with C18:1 and C20:1.
Toxicity of long-chain NEFAs in insulin-producing cells
Long-chain saturated NEFAs at a 100 μM concentration
were highly toxic to insulin-producing RINm5F cells. On
the other hand the corresponding unsaturated NEFAs
with the same chain lengths showed only a minimal or no
significant toxicity at a concentration of 100 μM com-
pared to the toxic effect of palmitic acid with a viability of
31 % (Additional file 1: Figure S1). Generally no correl-
ation between the toxicity and the number of double
bonds could be identified.
Protective capacity of long-chain unsaturated NEFAs
against the toxicity of palmitic acid in insulin-producing
cells in dependence on chain length and saturation level
The protective capacity of long-chain unsaturated NEFAs
was analyzed in co-incubation experiments of 200 μM PA
with increasing concentrations of unsaturated NEFAs to
determine the unsaturated NEFA concentration necessary
to achieve a 50 % viability reduction (Table 1). The best
protection against PA-induced toxicity in RINm5F
insulin-producing cells was provided by C20:5 with a
half-maximally effective protective concentration of
5.4 μM. Generally NEFAs of the C20:x group revealed the
highest protective potency. In the NEFA groups of C20:x
and C22:x the monounsaturated NEFAs were less protect-





























































































Fig. 2 Lipid droplet formation in rat insulin-producing RINm5F cells after incubation with unsaturated NEFAs with a different degree of unsaturation.
RINm5F cells were incubated with C18:x (a), C20:x (b) and C22:x (c) NEFAs (100 μM) with different numbers of double bonds for 24 h. Thereafter cells
were fixed and stained with Oil Red O. Lipid droplet formation was analyzed by fluorescence microscopy and quantified using the software
xcellence rt. Data are given as means ± SEM from 5 to 8 individual experiments. **p < 0.01, ***p < 0.001 compared with control cells (Dunnett’s
Multiple Comparison Test)
A B
Fig. 3 Lipid droplet formation in co-incubation experiments with unsaturated NEFAs in combination with increasing PA concentrations. RINm5F
cells were incubated with 100 μM of the unsaturated NEFAs C18:1 (a) or C20:1 (b) in combination with increasing concentrations of the saturated
NEFA C16:0 for 24 h. Thereafter cells were fixed, stained with Oil Red O and analyzed by fluorescence microscopy. Lipid droplet formation per cell
was quantified by the software xcellence rt. *p < 0.05, **p < 0.01, ***p < 0.001 compared to control cells (Dunnett’s Multiple Comparison Test).
#p < 0.05, ##p < 0.01, ###p < 0.005 compared to unsaturated NEFA only (Student’s t-test)
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17.2 μM for C20:1 and of 88.6 μM for C22:1 respectively
was required to antagonize PA toxicity by 50 %. With a
rise in the number of double bonds in these two groups
the protective potential increased. The group of C18:x un-
saturated NEFAs revealed the weakest protection of all
tested groups. There were no significant differences in the
protective potency against PA-induced toxicity between
the omega-9 fatty acid oleic acid (C18:1), the omega-6
fatty acid γ-linolenic acid (γ-C18:3) and the omega-3 fatty
acid α-linolenic acid (α-C18:3). The lowest protective po-
tency exhibited the omega-3 fatty acid C18:4.
Lack of correlation between protective potency against
PA-induced toxicity and lipid droplet formation in
insulin-producing cells
The most efficient unsaturated NEFA with respect to the
ability to form lipid droplets was C20:1, which mediated
only a moderate protection against PA-induced toxicity.
The highest protective potency against PA-induced tox-
icity revealed C20:5, but it showed no significant in-
crease in lipid droplet formation compared to control
conditions without NEFAs. To examine, whether there
was a correlation between the protective potency and
lipid droplet formation in the different unsaturated
NEFA groups (C18:x, C20:x, C22:x) the corresponding
correlation coefficients and the p values were calculated.
In none of the groups the correlation coefficient was
significant (Table 1). A calculation of an overall coeffi-
cient between lipid droplet formation and the protective
potency of the different NEFA groups revealed a correl-
ation coefficient of 0.04.
Gene expression analyses of perilipin 1 or 2 in
insulin-producing cells after suppression of perilipin 1 or 2
To verify the efficiency of the shRNA mediated knock-
down of perilipin 1 or 2 (shRNA-Plin1 or shRNA-Plin2)
gene expression in insulin-producing RINm5F and INS-
1E cells was analyzed after incubation with PA, OA
(oleic acid/cis-9-octadecenoic acid/C18:1), a combin-
ation of PA and OA, or GA (gondoic acid/cis-11-eicose-
noic acid/C20:1). Control INS-1E and RINm5F cells as
well as non-target shRNA control cells showed a signifi-
cant 3- to 4-fold increase in perilipin 1 gene expression
after incubation with OA, PA +OA, or GA in compari-
son to control conditions without NEFAs. In shRNA-
Plin1 cells no significant increase was detectable
(Fig. 4a-c). Similar results were obtained in shRNA-Plin2
cells. Only in control cells and non-target shRNA con-
trol cells a significant increase in perilipin 2 expression
was detectable, whereas the gene expression in shRNA-
Plin2 was not significantly increased after incubation with
OA, PA +OA, or GA in comparison to control conditions
(Fig. 4b-d).
In addition to the gene expression quantification the
mRNA level, perilipin 1 and 2 protein expression in
insulin-producing RINm5F and INS-1E cells was ana-
lyzed by immunoblotting (Fig. 5). In Western blot ana-
lyses two bands in the range between approx. 60 kDa
Table 1 Protective effect of unsaturated NEFAs against PA-induced toxicity and relative lipid droplet area linked with the correlation
coefficient for each group
NEFA Half-maximal protective
concentration (μM)
Lipid droplet area after
incubation with 100 μM





C18:1 32.8 ± 2.2 (6) 7.3 ± 1.3 (5) C18-FFA: +0.52 C18-FFA: 0.37
C18:2 11.4 ± 1.2 (5) 15.1 ± 2.8 (5)
α-C18:3 24.0 ± 1.8 (4) 2.4 ± 0.6 (5)
γ-C18:3 27.2 ± 1.6 (4) 2.6 ± 0.5 (5)
C18:4 > 100.0 (5) 1.9 ± 0.3 (5)
C20:1 17.2 ± 1.6 (6) 26.5 ± 4.9 (5) C20-FFA: −0.63 C20-FFA: 0.25
C20:2 6.0 ± 0.6 (4) 19.2 ± 2.9 (5)
C20:3 10.4 ± 1.2 (4) 8.1 ± 1.3 (5)
C20:4 8.6 ± 0.6 (4) 2.7 ± 0.6 (5)
C20:5 5.4 ± 0.6 (4) 3.9 ± 1.0 (5)
C22:1 88.6 ± 22.8 (6) 19.7 ± 4.1 (5) C22-FFA: −0.89 C22-FFA: 0.11
C22:2 42.0 ± 6.8 (4) 18.9 ± 2.7 (5)
C22:4 8.6 ± 1.4 (5) 12.1 ± 2.5 (5)
C22:6 10.8 ± 3.2 (5) 11.8 ± 2.4 (5)
Total value 0.04 0.89
The protective concentration of the unsaturated NEFAs was determined in co-incubation experiments for 24 h with 200 μM PA resulting in a 50 % cell viability
measured by MTT assay. The protective effects were calculated by nonlinear regression analyses. Lipid droplet and MTT data are means ± SEM with the number of
independent experiments in parenthesis. Correlation coefficients and P values were determined by Pearson correlation
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and 65 kDa were detectable for perilipin 1. This finding
confirms earlier immunoblotting analyses of INS-1E
cells [13]. For perilipin 2 the immunoblotting revealed a
specific band at a molecular weight of 48 kDa. Through
shRNA mediated suppression of perilipin 1 or perilipin 2
a 60 to 70 % reduction both on the mRNA and protein
level was achieved after incubation with OA, PA +OA,
or GA, when compared to non-targeted control cells
(Fig. 5). PA alone did not induce expression of perilipin
1 or 2. This low expression level was also not affected by
shRNA mediated perilipin suppression.
Quantification of lipid droplet formation in
insulin-producing cells after exposure to oleic acid
In order to verify the effect of perilipins on LD forma-
tion shRNA-Plin1 or shRNA-Plin2 RINm5F and shRNA-
Plin1 or shRNA-Plin2 INS-1E cells were incubated with
the physiologically most important NEFAs, the saturated
palmitic acid, (PA, C16:0) and the monounsaturated
oleic acid (OA, C18:1) as well as a combination of both.
Maximal LD formation was induced in RINm5F and INS-
1E control cells or shRNA non-target controls (shNTC)
after OA incubation in comparison to cells incubated
without this NEFA (Fig. 6a and b). In shRNA-Plin1 or
shRNA-Plin2 cells C18:1 exposure resulted in a non-
significant increase in LD formation in comparison to cells
not incubated with OA. Furthermore shRNA-Plin1 or
shRNA-Plin2 cells generated significantly fewer LDs in re-
sponse to OA when compared to non-suppressed perilipin
cells. The reduction in LD formation was in INS-1E-
shPlin cells approx. 80 % (Fig. 6a) and in RINm5F-shPlin
cells approx. 50 % (Fig. 6b). Incubation of RINm5F and
INS-1E cells with knockdown of perilipin 1 or 2 in the
presence of PA (200 μM) plus OA (100 or 200 μM) also
caused a significant reduction of lipid droplet formation in
the range of 50–70 % in comparison with the respective
shNTC control cells (Fig. 6c and d). PA (200 μm) alone
did not cause lipid droplet formation (data not shown).
Palmitic acid-induced lipotoxicity in perilipin suppressed
insulin-producing cells
Perilipin suppressed RINm5F and INS-1E cells were used
to analyze differences in the sensitivity against PA-induced
toxicity. Neither perilipin 1 suppression nor perilipin 2
suppression showed a significantly higher sensitivity when
compared to non-target shRNA control cells after incuba-
tion with the toxic saturated NEFA PA (C16:0) (Fig. 7a





































































































































































Fig. 4 Gene expression analysis of perilipin 1 or 2 suppressed RINm5F and INS-1E cells. Perilipin 1 and 2 expression in RINm5F (a, c) and INS-1E
(b, d) cells was stably suppressed by the shRNA technique after lentiviral transduction. Cells were incubated with 100 μM palmitic acid (PA),
100 μM oleic acid (OA), a combination of both, or 100 μM gondoic acid (GA) or without NEFAs (Con) for 24 h. Thereafter RNA was isolated and
reverse transcribed into cDNA. Gene expression of perilipin 1 and perilipin 2 was measured by qRT-PCR and normalized to the reference genes
PPIA, α-tubulin and β-actin using qBase + software (Biogazelle). Data are means ± SEM of n = 4. *p < 0.01 compared to control cells without
NEFAs (ANOVA/Tukey Multiple Comparison Test). #p < 0.01 compared with control cells (ANOVA/Tukey Multiple Comparison Test)
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200 μM PA and increasing concentrations of OA (up to
200 μM) demonstrating the protective effect of the mono-
unsaturated NEFA OA on PA-induced toxicity. In these
experiments there were also no significant differences in
toxicity detectable between perilipin 1 or 2 suppressed cell
lines detectable (Fig. 7c and d). Incubation with OA (up to
500 μM) alone did not induce significant toxicity in the
cell lines (data not shown).
Discussion
Obesity and the metabolic syndrome are associated
with increased plasma concentrations of non-esterified
fatty acids (NEFAs) concentrations in the circulation,
which can cause T2DM by inducing insulin resistance
in peripheral tissues as well as damage to pancreatic β-
cells [1, 2]. In several in vitro studies on lipotoxicity in
rodent β-cells long-chain saturated NEFAs were found
to be responsible for the induction of apoptosis by ER-
stress [25–27] or the formation of toxic reactive oxygen
species (ROS) [7, 28–30]. In contrast, long-chain unsat-
urated NEFAs are less toxic or non-toxic to rat β-cells
and can even provide protection against the toxicity in-
duced by long-chain saturated NEFAs. We recently re-
ported that the PA-induced formation of cytotoxic
H2O2 in the peroxisomal β-oxidation is inhibited by



























































































































Fig. 5 Western blot analyses of perilipin 1 or 2 suppressed RINm5F and INS-1E cells. Perilipin 1 and 2 expression in RINm5F (a, c) and INS-1E
(b, d) cells was stably suppressed by the shRNA technique after lentiviral transduction. Cells were incubated with 100 μM palmitic acid (PA),
100 μM oleic acid (OA), a combination of both, or 100 μM gondoic acid (GA) or without NEFAs (Con) for 24 h. Thereafter, 30 μg protein of total
whole cell extracts were separated by a SDS-PAGE and electroblotted on nitrocellulose membranes. Specific protein detection was carried out with a
primary anti-perilipin 1 or anti-perilipin 2 antibody and a horseradish peroxidase labelled anti-rabbit IGG secondary antibody. After visualization of
the protein bands by chemiluminescence the perilipin 1 and 2 bands were quantified and normalized to β-actin bands. Shown are means
of ± SEM of n= 3 independent immunoblots and one representative blot for each cell line. *p< 0.01 compared to control cells without NEFAs (ANOVA/
Tukey Multiple Comparison Test). #p < 0.01 compared with control cells (ANOVA/Tukey Multiple Comparison Test)
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do not express the H2O2 detoxifying enzyme catalase
which contributes to the exceptional sensitivity towards
ROS mediated toxicity of this cell type [11, 31].
Another concept offered to explain the protection of
long-chain unsaturated NEFAs against lipotoxicity is the
formation of cytosolic lipid droplets (LDs). NEFAs in the
cytosol can be sequestrated to LDs after esterification in
triglycerides and could therefore not express their cyto-
toxic action [13, 32, 33]. PA is known to be incorporated
into LDs to a significantly lesser extent and evokes a
greater lipotoxic effect than OA [32–34]. Furthermore,
when cells are incubated with PA and OA simultan-
eously, OA induces LD formation and facilitates the in-
corporation of PA into the LDs, and thereby is thought
to decrease the lipotoxic action of PA [33]. It was there-
fore the aim of the present study to verify if this hypoth-
esis is applicable not only to OA but also to other
unsaturated NEFAs with different chain lengths and sat-
uration levels in rat insulin-producing cells.
In a comprehensive experimental approach we ana-
lyzed for the first time a group of 16 different saturated
as well as mono- and polyunsaturated NEFAs with
chain lengths ranging from C12 to C24 by fluorescence
microscopy for their ability to form LDs in insulin-
producing cells. Only long-chain mono- and polyunsat-
urated NEFAs were found to cause LD formation
whereas the saturated NEFAs were ineffective. Such a
difference had been reported in previous studies only
between the unsaturated NEFA OA and the unsatur-
ated NEFA PA [13, 32, 33, 35]. Our detailed compari-
son of different mono- and polyunsaturated NEFAs
with chain lengths of C18, C20 and C22 revealed no
correlation (correlation coefficient r = 0.04) between ex-
tent of NEFAs saturation and LD formation.
These results are in disagreement with the previ-
ously proposed hypothesis that LD formation is re-
sponsible for the protective effect of unsaturated
NEFAs against toxicity of long-chain saturated NEFAs
[13, 32, 33, 35]. To obtain further evidence for a lack
of association between LD formation and a possible
protective effect of unsaturated NEFAs against the
toxicity of the saturated NEFA PA we determined in
RINm5F insulin-producing cells in co-incubation ex-
periments with 200 μM PA the half maximal protect-
ive concentration for each of the 14 unsaturated
NEFAs with different chain lengths and saturation
levels and correlated these data with the LD forma-
tion. Interestingly, there was no correlation detectable
Fig. 6 Effect of perilipin 1 or 2 suppression in insulin-producing RINm5F and INS-1E cells on lipid droplet formation after OA and PA incubation.
For the suppression of perilipin 1 and 2 RINm5F (a, c) and INS-1E (b, d) cells were transduced lentivirally with the respective shRNA constructs or
as a control with a non-target shRNA (shNTC). Cells were incubated with the indicated NEFAs for 24 h and after fixation stained with Oil Red O.
Lipid droplet formation was analyzed by fluorescence microscopy and quantified using the software xcellence rt. a, b Cells were incubated with
100 μM oleic acid (C18:1, OA) or under control conditions (Con). Data are presented as means ± SEM of 4 to 5 independent experiments. ##p <
0.01; ###p < 0.001 compared with shNTC cells after incubation with OA (ANOVA/Tukey Multiple Comparison Test). ***p < 0.001 compared with
non-OA-incubated controls (ANOVA/Tukey Multiple Comparison Test). c, d Cells were incubated with 200 μM palmitic acid (PA) in combination
with 100 or 200 μM OA. Data are presented as means ± SEM of 4 independent experiments. *p < 0.05; compared with shNTC cells with the
respective PA and OA concentrations (ANOVA/Tukey Multiple Comparison Test)
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between toxicity and LD formation. This conclusion is
in contradiction to the hypothesis of a crucial role of
LDs for the protection against PA toxicity [13, 31, 32],
which was based only on analyses of the effects of PA,
OA and linoleic acid [13, 35]. Thus a valid conclusion
must be based upon the analyses of more than these
three NEFAs.
Additional evidence that LD formation is not a cru-
cial protective mechanism against lipotoxicity was pro-
vided by the perilipin 1 and 2 repression experiments
in insulin-producing cells. Perilipin repression was used
as an additional experimental tool to study the effect of
LD formation on lipotoxicity. Perilipins are proteins
which are involved in the biogenesis of LDs and located
in the phospholipid mono layer of the LDs [16, 17].
Like other investigators [13] we were able to detect perili-
pin 1 and 2 gene expression in rat insulin-producing
RINm5F and INS-1E cells on the mRNA as well as on the
protein level. Incubation with OA, PA +OA, or GA led to
an approx. 3 to 4-fold increase in perilipin 1 and 2 mRNA
and protein expression. This induced perilipin 1 and 2 ex-
pression was diminished by the shRNA technique by 60 %
to 80 %. This gene suppression caused also a 50-80 % re-
duction in LD formation in insulin-producing cells indi-
cating that perilipins are involved in LD formation. If LD
formation would be of crucial importance for lipotoxicity
of long-chain saturated NEFAs it should be expected, that
the protection of OA against PA-induced toxicity was re-
duced in perilipin 1 and 2 repressed cells which was not
the case in our experiments. On the other hand we ob-
tained also no experimental evidence for a short-term detri-
mental effect on cell viability of LD storing unsaturated
fatty acids. This does not exclude that long-term intracellu-
lar storage of fatty acids in the form of triglycerides may
have unfavorable effects on the cellular function; in particu-
lar in diseases affecting other organs such as non-alcoholic
fatty liver [36] and cardiovascular diseases [37], which go
along with pathological intracellular fat accumulation.
Conclusions
The results document convincingly that LD formation
plays no essential role in the protective effect of unsatur-
ated NEFAs against the toxicity of palmitic acid in rat
insulin-producing cells.
Additional file
Additional file 1: Figure S1. Viability of long-chain unsaturated NEFAs
in comparison to the long-chain saturated NEFA PA (C16:0). RINm5F
cells were incubated with 100 μM of the long-chain saturated NEFA or
100 μM of the unsaturated NEFAs as depicted for 24 h. Thereafter viability
was measured by MTT assay. Data are means ± SEM of n = 5 to 8.
*p < 0.05, **p < 0.01, ***p < 0.001 compared to cells incabated under
control condition without NEFAs (Dunnett’s Multiple Comparison
Test). (DOCX 34 kb)
































































Fig. 7 PA-induced lipotoxicity and OA protection against PA-induced lipotoxicity in perilipin 1 or 2 suppressed insulin-producing RINm5F and
INS-1E cells. Perilipin 1 or 2 suppressed RINm5F cells were incubated with increasing concentrations of the saturated NEFA C16:0 (PA) (a) or
co-incubated with 200 μM PA and increasing concentrations of the monounsaturated NEFA C18:1 (OA) (c). Perilipin 1 or 2 suppressed INS-1E
cells were incubated with increasing concentrations of the saturated NEFA C16:0 (PA) (b) or co-incubated with 500 μM PA and increasing concentrations
of the monounsaturated NEFA C18:1 (OA) (d). The cell viability was measured by MTT assay after 24 h. Data are means ± SEM of n = 4 to 6.
Significance was tested against control cells (ANOVA/Tukey Multiple Comparison Test)
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